Caspase-12 controls West Nile virus infection via the viral RNA receptor RIG-I

Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Nature Immunology (Impact Factor: 24.97). 10/2010; 11(10):912-9. DOI: 10.1038/ni.1933
Source: PubMed

ABSTRACT Caspase-12 has been shown to negatively modulate inflammasome signaling during bacterial infection. Its function in viral immunity, however, has not been characterized. We now report an important role for caspase-12 in controlling viral infection via the pattern-recognition receptor RIG-I. After challenge with West Nile virus (WNV), caspase-12-deficient mice had greater mortality, higher viral burden and defective type I interferon response compared with those of challenged wild-type mice. In vitro studies of primary neurons and mouse embryonic fibroblasts showed that caspase-12 positively modulated the production of type I interferon by regulating E3 ubiquitin ligase TRIM25-mediated ubiquitination of RIG-I, a critical signaling event for the type I interferon response to WNV and other important viral pathogens.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Abstract The innate immune system represents the first line of defense against infectious agents, and co-ordinates cellular and molecular mechanisms that result in effective inflammatory and anti-microbial responses against pathogens. Infection and cellular stress trigger assembly of canonical and non-canonical inflammasome complexes that activate the inflammatory caspases-1 and -11, respectively. These inflammatory caspases play key roles in innate immune responses by inducing pyroptosis to halt intracellular replication of pathogens, and by engaging the extracellular release of pro-inflammatory cytokines and danger signals. In addition, the inflammatory caspases-4, -5 and -11 were recently shown to directly bind microbial components. Although the immune roles of caspase-12 are debated, it was proposed to dampen inflammatory responses by interfering with caspase-1 activation and other innate immune pathways. Here, we recapitulate the reported roles of inflammatory caspases with an emphasis on recent insights into their biological functions.
    Biological Chemistry 11/2014; 396(3). DOI:10.1515/hsz-2014-0253 · 2.69 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction ReDuNing (RDN), a patented traditional antipyretic-detoxicate Chinese medicine, has been widely applied as an anti-inflammatory and anti-infectious drug in Chinese clinics. However, relative experimental data on anti-influenza virus and its subsequent viral pneumonia by RDN are limited. In this study, restraint stress mice model, which could mimic the physiological conditions of the population susceptible to influenza infection, was applied to investigate the protective effect of RDN against influenza. Methods Mice were infected with H1N1 influenza virus 3 days after restraint, and RDN were administered to mice the day after stress by intraperitoneal injection for 7 days. Body weight and mortality were recorded every day. Histopathologic changes, lung index, nucleoprotein (NP) gene expressions and inflammatory markers in lungs were also measured. Results RDN administration significantly decreased lung index, ameliorated lung histopathologic damage and decreased lung NP gene expression in influenza-infected mice loaded with restraint stress. It also decreased phosphorylated inhibitor of nuclear factor kappaB (p-IκB), nuclear factor-kappa B (NF-κB) protein level and interleukin-1β (IL-1β) mRNA expression, increased interferon inducible transmembrane 3 (IFITM3) and mitochondrial antiviral signaling (MAVS) gene expression. Conclusions This study provided preliminary support to suggest that RDN can reduce the susceptibility to, and the severity of influenza in restraint-stressed mice. The study also supported the potential of implementing RDN as an antiviral and its impact as potential anti-influenza medication which rebalances homeostasis in the body caused by stress.
    European Journal of Integrative Medicine 08/2014; DOI:10.1016/j.eujim.2014.07.018 · 0.65 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: West Nile virus (WNV) is a mosquito-borne enveloped positive-strand RNA virus that emerged in North America in 1999 in New York City. Over the past 15 years, WNV has become established throughout the USA and has spread into Canada, Mexico and the Caribbean. CDC reports indicate >41,000 clinical cases, including more than 1700 fatalities. An estimated 3 million people in the USA may have been infected to date. Infection with WNV is dependent on many factors including climate, mosquito habitats and immunologically naïve bird populations. In addition, variations within individuals contribute to the risk of severe disease, in particular, advanced age, hypertension, immunosuppression and critical elements of the immune response. Recent advances in technology now allow detailed analysis of complex immune interactions relevant to disease susceptibility.
    Expert Review of Anti-infective Therapy 01/2015; DOI:10.1586/14787210.2015.1007043 · 2.28 Impact Factor

Full-text (2 Sources)

Available from
Jun 2, 2014

Penghua Wang